ABVX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Abivax will present new data on obefazimod at United European Gastroenterology Week 2026Sep 30, 2026
- Abivax reported a positive pre-NDA meeting with the FDA for obefazimodJul 31, 2026
- Abivax announces patient-reported outcomes data from Phase 3 ABTECT induction trials of Obefazimod, demonstrating significant improvements in quality of life for patients with moderate-to-severely active ulcerative colitisNov 4, 2025
- Abivax announces late-breaking presentation of 8-week ABTECT induction trial results in participants with and without prior inadequate response to advanced therapiesOct 6, 2025
- Abivax announces presentation of late-breaking abstract for Obefazimod from ABTECT Phase 3 induction trials at 2025 United European Gastroenterology (UEG) meetingSep 24, 2025